Mr Fibig is chair and chief executive officer of International
Flavors & Fragrances Inc., based in the US.
Mr Fibig is chair of the German American Chamber of Commerce and
an executive committee member of the World Business Council for
Sustainable Development (WBCSD).
From 2008 to 2014, Mr Fibig was president and chair of the board of
management of Bayer HealthCare Pharmaceuticals, a division of Bayer
AG, Germany. Previously, Mr Fibig held several positions of increasing
responsibility at Pfizer Inc., including senior vice president of the
US Pharmaceutical Operations from 2007 to 2008, and as president of
Latin America, Africa and Middle East from 2006 to 2007. Prior to
that, Mr Fibig served as market company president at Pharmacia
Corporation in Germany from 2000 to 2003. From 1984 to 1999 Mr Fibig
held a series of leadership positions at Boehringer Ingelheim GmbH, Germany.
Mr Fibig was first elected to the Board of Novo Nordisk A/S in March
2018 and has most recently been re-elected in March 2020. His term as
a board member expires in March 2021.
In March 2020 the Board of Directors of Novo Nordisk A/S assessed
that Mr Fibig is regarded as an independent board member as defined in
Section 3.2.1 of the Recommendations on Corporate Governance
designated by Nasdaq Copenhagen.
Mr Fibig became member of the Audit Committee at Novo Nordisk A/S
in March 2018. In March 2020 the Board of Directors of Novo Nordisk
A/S assessed that Mr Fibig qualifies as independent pursuant to the
US Securities Exchange Act.
In January 2020, the Board of Directors assessed that the special
competencies possessed by Mr Fibig that are important for the
performance of his duties are his extensive global experience within
biopharmaceutical companies, in-depth knowledge of strategy, sales and
marketing and knowledge about how large international companies operate.
1982: Degree in Marketing, Berlin School of Economics, Germany.
Mr Fibig is a German national, born February 1962.